Lotus Pharmaceutical Co Ltd (1795) — Long-term Investment Intensity
Lotus Pharmaceutical Co Ltd (1795) has a Long-term Investment Intensity of 2.6% as of December 2019. Long-term investments of NT$458.06 Million represent 2.6% of total assets of NT$17.92 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check how aggressively does Lotus Pharmaceutical Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Lotus Pharmaceutical Co Ltd Long-term Investment Intensity (2016–2019)
This chart shows how Lotus Pharmaceutical Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2016 to 2019. As of December 2019, the intensity stands at 2.6%, reflecting long-term investments of NT$458.06 Million against total assets of NT$17.92 Billion TWD. Explore how well can Lotus Pharmaceutical Co Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Lotus Pharmaceutical Co Ltd (2016–2019)
The table below presents the year-by-year Long-term Investment Intensity for Lotus Pharmaceutical Co Ltd from 2016 to 2019, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see 1795 company net worth.
| Year | LT Investment Intensity | LT Investments (TWD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 2.6% | NT$458.06 Million | NT$17.92 Billion | ▲ +2.5 pp |
| 2018 | 0.1% | NT$9.04 Million | NT$14.85 Billion | ▼ 0.0 pp |
| 2017 | 0.1% | NT$10.52 Million | NT$15.66 Billion | ▼ -0.1 pp |
| 2016 | 0.1% | NT$20.11 Million | NT$15.24 Billion | — |